What is the impact of capsule endoscopy in the long term period?

dc.authorid0000-0001-8532-4917
dc.contributor.authorÖrmeci, Aslı
dc.contributor.authorAkyüz, Filiz
dc.contributor.authorBaran, Bülent
dc.contributor.authorGöktürk, Suut
dc.contributor.authorÖrmeci, Tuğrul
dc.contributor.authorPınarbaşı, Binnur
dc.contributor.authorSoyer Mutluay, Özlem
dc.contributor.authorEvirgen, Sami
dc.contributor.authorAkyüz, Ümit
dc.contributor.authorKaraca, Çetin
dc.contributor.authorDemir, Kadir
dc.contributor.authorKaymakoğlu, Sabahattin
dc.contributor.authorBeşışık, Fatih
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T20:04:39Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T20:04:39Z
dc.date.issued2016
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyoloji Ana Bilim Dalı
dc.descriptionWOS: 000373288400004
dc.descriptionPubMed ID: 27076873
dc.description.abstractAIM: To assess the clinical impact of capsule endoscopy (CE) in the long-term follow-up period in patients with obscure gastrointestinal bleeding (OGIB). METHODS: One hundred and forty-one patients who applied CE for OGIB between 2009 and 2012 were retrospectively analyzed, and this cohort was then questioned prospectively. Demographic data of the patients were determined via the presence of comorbid diseases, use of non-steroidal anti-inflammatory drugs anticoagulant-antiaggregant agents, previous diagnostic tests for bleeding episodes, CE findings, laboratory tests and outcomes. RESULTS: CE was performed on 141 patients because of OGIB. The capsule was retained in the upper gastrointestinal (GI) system in two of the patients, thus video monitoring was not achieved. There were 139 patients [62% male, median age: 72 years (range: 13-93 years) and a median follow-up duration: 32 mo (range: 6-82 mo)]. The overall diagnostic yield of CE was 84.9%. Rebleeding was determined in 40.3% (56/139) of the patients. The rebleeding rates of patients with positive and negative capsule results at the end of the follow-up were 46.6% (55/118) and 4.8% (1/21), respectively. In the multivariate analysis, usage of NSAIDs, anticoagulant-antiaggregant therapies (OR = 5.8; 95% CI: 1.86-18.27) and vascular ectasia (OR = 6.02; 95% CI: 2.568-14.146) in CE were detected as independent predictors of rebleeding. In the univariate analysis, advanced age, comorbidity, and overt bleeding were detected as predictors of rebleeding. CONCLUSION: CE is a reliable method in the diagnosis of obscure GI bleeding. Negative CE correlated with a significantly lower rebleeding risk in the long-term follow-up period.
dc.identifier.citationÖrmeci, A., Akyüz, F., Akyüz, F., Göktürk, S., Örmeci, T., Pınarbaşı, B. ... Beşışık, F. (2016). What is the impact of capsule endoscopy in the long term period? World Journal Of Gastrointestinal Endoscopy, 8(7), 344-348. https://dx.doi.org/10.4253/wjge.v8.i7.344
dc.identifier.doi10.4253/wjge.v8.i7.344
dc.identifier.endpage348
dc.identifier.issn1948-5190
dc.identifier.issue7
dc.identifier.startpage344
dc.identifier.urihttps://dx.doi.org/10.4253/wjge.v8.i7.344
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4087
dc.identifier.volume8
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBaishideng Publishing Group Inc
dc.relation.ispartofWorld Journal Of Gastrointestinal Endoscopyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCapsule Endoscopy
dc.subjectSmall Bowel
dc.subjectObscure Gastrointestinal Bleeding
dc.subjectRebleeding
dc.titleWhat is the impact of capsule endoscopy in the long term period?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Ormecı-Tugrul 2016.pdf
Boyut:
885.96 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text